Data Elements: Company.aspx
Novo A/S was established in 1999 and is fully owned by the Novo Nordisk Foundation, an independent Danish foundation with corporate interests and a history going back to 1923. Novo A/S oversees, invests and manages the assets of the Novo Nordisk Foundation valued at more than EUR 47 billion. Novo Ventures is one of the most active life science venture capital investors in the world. So far, they have invested DKK 8 billion in more than 120 companies and successfully exited over 30 companies through trade sales and IPOs.